glp-1 nature medicine Study identifies benefits, risks linked to popular weight-loss drugs. The journal Nature Made GLP-1 Companion Health

The GLP-1R Agonist-Like Effects of Cinchonine Identified by CMap Analysis The CMap database was used to screen candidate small-molecule drugs

For example, patients unfamiliar with using syringes have accidentally administered 520 times the intended dose, and providers have miscalculated conversions from milligrams to units, leading to severe side effects and in some instances hospitalization

Daily use provides better results compared to irregular intake

Lastly as the majority of GLP-1 RAs in this study were semaglutide, this may not apply to all GLP-1 RAs and additionally, because the analysis excluded over 26,000 patients who could not be matched, the results may not apply to the full spectrum of patients taking these drugs in the real world, particularly those with more complex health profiles. MNT spoke with David I

UV INDEX: Check the current and daily peak UVI, and the two day UV forecast for any location across the globe